Entrepreneurship in Cell & Gene Therapy (CGT) and Healthcare in the digital era.
The Korean-American Scientists and Engineers Association (KSEA) will host the 3rd Science and Technology Entrepreneurship Partners’ Upscale Program (STEP-UP) in New York (and ONLINE as a hybrid event) for 4 days from May 23th, 2022. Its mission is to promote and enrich the KSEA members’ entrepreneurship as well as to discuss the success of innovative companies, particularly in the domains of cell & gene therapy (CGT) and healthcare in the digital era.
Register now to step up your future!
Donghoon Lee, Executive Vice President at SK Inc.
Mr. Lee is currently a head of Bio Investment Center at SK Inc, an investment holding company of SK group.
He is leading SK group’s bio investment globally by serving as a chairman of BOD at SK Biopharm and as a board member at SK Pharmteco.
Formerly, he was a head of global business at Donga ST and CEO of Donga Socio Holdings.
Prior to joining Donga, he practiced as a partner at Samjong KPMG Investment Advisory in Korea.
He has MBA from The Ohio State University and BBA from Seoul National University.